Stifel Expands Venture Banking Team to Accelerate Growth in Life Sciences and Healthcare Sectors
Stifel Financial Corp. (NYSE: SF) has announced a significant expansion of its Venture Banking team with the addition of several senior bankers from Silicon Valley Bank, focusing on life sciences and healthcare sectors. The expansion is led by six Managing Directors - Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew, and Sam Subilia - along with three Vice Presidents.
The move strengthens Stifel's Venture & Fund Banking division, which has already achieved notable growth with over 100 bankers, more than $10 billion in loan commitments, and doubled venture client deposits in the past year. The company has recently demonstrated its market strength by acting as joint bookrunner on 4 biopharma financings totaling $1.1 billion, including the first biopharma IPO in seven months.
This strategic expansion enhances Stifel's capabilities in supporting innovation-driven companies across biotech, diagnostics and tools, medical devices, and healthtech sectors.
Stifel Financial Corp. (NYSE: SF) ha annunciato una significativa espansione del suo team Venture Banking con l'aggiunta di diversi banchieri senior provenienti da Silicon Valley Bank, con focus sui settori life sciences e healthcare. L'espansione è guidata da sei Managing Directors — Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew e Sam Subilia — insieme a tre Vice Presidents.
Questo movimento rafforza la divisione Venture & Fund Banking di Stifel, che ha già registrato una notevole crescita con oltre 100 banchieri, oltre 10 miliardi di dollari in impegni di prestito e il raddoppio dei depositi dei clienti venture nell'ultimo anno. L'azienda ha recentemente dimostrato la propria forza sul mercato agendo come joint bookrunner in 4 finanziamenti biopharma per un totale di 1,1 miliardi di dollari, inclusa la prima IPO biopharma in sette mesi.
Questa espansione strategica potenzia la capacità di Stifel di supportare aziende guidate dall'innovazione nei settori biotech, diagnostica e strumenti, dispositivi medici e healthtech.
Stifel Financial Corp. (NYSE: SF) ha anunciado una expansión significativa de su equipo de Venture Banking con la incorporación de varios banqueros senior provenientes de Silicon Valley Bank, enfocándose en los sectores de ciencias de la vida y atención sanitaria. La expansión está liderada por seis Directores Gerentes — Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew y Sam Subilia — junto con tres Vice Presidents.
El movimiento fortalece la división de Venture & Fund Banking de Stifel, que ya ha registrado un notable crecimiento con más de 100 banqueros, más de 10 mil millones de dólares en compromisos de préstamo y el doble de depósitos de clientes venture en el último año. La compañía ha demostrado recientemente su fortaleza en el mercado al actuar como joint bookrunner en 4 financiaciones biofarmacéuticas por un total de 1,1 mil millones de dólares, incluida la primera IPO biofarmacéutica en siete meses.
Esta expansión estratégica mejora las capacidades de Stifel para apoyar a empresas impulsadas por la innovación en biotecnología, diagnósticos y herramientas, dispositivos médicos y sectores healthtech.
Stifel Financial Corp. (NYSE: SF)는 실리콘밸리 뱅크에서 온 다수의 시니어 은행가들을 영입해 생명과학 및 헬스케어 부문에 초점을 맞춘 Venture Banking 팀을 대폭 확장했다고 발표했다. 확장은 Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew, Sam Subilia 여섯 명의 Managing Directors와 세 명의 Vice Presidents가 이끈다.
이 움직임은 지난 해 이미 100명 이상의 은행가, 100억 달러 이상의 대출 약정, 벤처 고객 예금의 두 배 증가라는 성과를 거둔 Stifel의 Venture & Fund Banking 부서를 강화한다. 이 회사는 최근 4건의 바이오파마 파이낸싱 합산 11억 달러에서 공동 북런저로 활동하며 7개월 만에 첫 바이오파마 IPO를 포함해 시장에서의 강점을 입증했다.
이 전략적 확장은 바이오 기술, 진단 및 도구, 의료기기, 헬스테크 부문에서 혁신 주도 기업들을 지원하는 Stifel의 역량을 향상시킨다.
Stifel Financial Corp. (NYSE: SF) a annoncé une expansion significative de son équipe Venture Banking avec l'arrivée de plusieurs banquiers seniors de Silicon Valley Bank, en mettant l'accent sur les secteurs des sciences de la vie et des soins de santé. L'expansion est dirigée par six Directeurs Généraux — Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew et Sam Subilia — ainsi que trois Vice-Présidents.
Cette expansion renforce la division Venture & Fund Banking de Stifel, qui a déjà enregistré une croissance notable avec plus de 100 banquiers, plus de 10 milliards de dollars en engagements de prêts et le doublement des dépôts des clients venture au cours de l'année écoulée. L'entreprise a récemment démontré sa force sur le marché en agissant en tant que joint bookrunner sur 4 financements biopharmaceutiques totalisant 1,1 milliard de dollars, y compris la première IPO biopharmaceutique en sept mois.
Cette expansion stratégique renforce les capacités de Stifel à soutenir les entreprises axées sur l'innovation dans les secteurs biotech, diagnostics et outils, dispositifs médicaux et healthtech.
Stifel Financial Corp. (NYSE: SF) hat eine bedeutende Erweiterung seines Venture-Banking-Teams angekündigt, indem mehrere Senior-Banker der Silicon Valley Bank ins Unternehmen gewechselt sind, mit Schwerpunkt auf Life-Sciences- und Gesundheitssektoren. Die Expansion wird von sechs Managing Directors — Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew und Sam Subilia — sowie drei Vice Presidents geleitet.
Dieser Schritt stärkt die Venture & Fund Banking-Abteilung von Stifel, die bereits bemerkenswert gewachsen ist, mit über 100 Bankern, mehr als 10 Milliarden Dollar an Kreditverpflichtungen und einer Verdopplung der Deposits von Venture-Kunden im vergangenen Jahr. Das Unternehmen hat seine Marktstärke kürzlich gezeigt, indem es als Joint Bookrunner bei 4 Biopharma-Finanzierungen im Gesamtwert von 1,1 Milliarden Dollar fungierte, einschließlich des ersten Biopharma-IPO binnen sieben Monaten.
Diese strategische Expansion erhöht Stifels Fähigkeiten, innovationsgetriebene Unternehmen in den Bereichen Biotech, Diagnostics & Tools, Medical Devices und Healthtech zu unterstützen.
Stifel Financial Corp. (NYSE: SF) أعلنت عن توسيع كبير لفريق Venture Banking من خلال إضافة عدة بنوك كبار من Silicon Valley Bank، مع تركيز على قطاعات علوم الحياة والرعاية الصحية. تقود هذه التوسعة ستة مدراء إدارة — جاكي سبنسر، أنطوني فلوريس، ميلو بيسين، جولي إبرت، تيموثي ليو، وسام سبوليّا — إلى جانب ثلاثة نواب رؤساء.
وتعزز هذه الخطوة قسم Venture & Fund Banking في Stifel، الذي حقق نمواً ملحوظاً بالفعل بوجود أكثر من 100 بنّاك، وأكثر من 10 مليارات دولار في التزامات القروض، ومضاعفة ودائع عملاء Venture خلال العام الماضي. كما أظهرت الشركة قوتها في السوق من خلال كونها مشترِّك كتاب مشترك في 4 تمويلات بايوفارماسيوتيكل بإجمالي 1.1 مليار دولار، بما في ذلك أول IPO في البيوفارما خلال سبعة أشهر.
هذا التوسع الاستراتيجي يعزز قدرات Stifel في دعم الشركات المبتكرة عبر قطاعات البيوتكنولوجي والتشخيصات والأدوات، الأجهزة الطبية وHealthtech.
Stifel Financial Corp.（纽约证券交易所代码：SF）宣布大幅扩张其风险投资银行团队，从硅谷银行引入多位资深银行家，重点关注生命科学和医疗保健领域。此次扩张由六位常务董事——Jackie Spencer、Anthony Flores、Milo Bissin、Julie Ebert、Timothy Lew和Sam Subilia——以及三位副总裁带领。
此次举措增强了Stifel的风险投资与基金银行部，过去一年已实现显著增长，拥有超过100名银行家、超过100亿美元的贷款承诺，以及风险投资客户存款翻倍。该公司近期已证明其市场实力，作为4笔生物制药融资的共同承销商，总额11亿美元，其中还包括七个月内首只生物制药IPO。
这一战略扩张提升了Stifel在支持以创新为驱动的生物技术、诊断和工具、医疗设备以及健康科技等领域的能力。
- None.
- None.
ST. LOUIS, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced a major expansion of its Venture Banking team, welcoming a new group of senior bankers, formerly from Silicon Valley Bank, who bring deep expertise across the life sciences and healthcare ecosystem. This strategic move reinforces Stifel’s commitment to supporting innovation-driven companies and investors in sectors such as biotech, diagnostics and tools, medical devices, and healthtech.
The new hires are led by Managing Directors Jackie Spencer, Anthony Flores, Milo Bissin, Julie Ebert, Timothy Lew, and Sam Subilia, all recognized for their success in venture banking, corporate finance, and strategic advisory. Collectively, they have advised and supported hundreds of early- and growth-stage companies, with backgrounds spanning commercial banking, venture debt, and investment banking at leading institutions. Vice Presidents Tessa Dibble, Lindsey Seidner, and Ariana DaCruz also join Stifel as part of the senior team.
This expansion builds on Stifel Bank’s recent momentum in Venture & Fund Banking, which has seen the team grow to over 100 bankers, more than
“Stifel is proud to be a leading partner to the innovation ecosystem,” said Ronald J. Kruszewski, Chairman and CEO of Stifel. “Adding this talented team further strengthens our capabilities in healthcare and life sciences and expands the resources we provide to founders and investors.”
“The life sciences and healthcare sectors are at a critical inflection point, driven by the transformative potential of AI,” noted Jackie Spencer. “We are excited to bring our expertise to Stifel’s broader platform, which is uniquely positioned to provide founders and management teams with the resources and solutions to scale from inception to exit.”
Beyond venture banking, Stifel’s life sciences and healthcare focus spans equity research, capital raising, mergers and acquisitions, plus proprietary conferences and events. Since early September, Stifel has acted as joint bookrunner on 4 biopharma financings raising
Stifel Company Information
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust, Members FDIC, offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A., Members FDIC, offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.
Media Contact
Neil Shapiro, +1 (212) 271-3447
shapiron@stifel.com
Investor Relations Contact
Joel Jeffrey, +1 (212) 271-3610
investorrelations@stifel.com
FAQ
What major expansion did Stifel (NYSE:SF) announce in September 2025?
How large is Stifel's Venture & Fund Banking division as of 2025?
Who are the key Managing Directors joining Stifel's Venture Banking team?
What recent biopharma financing achievements has Stifel (SF) accomplished?
How will this expansion affect Stifel's healthcare and life sciences capabilities?
